Assuming the RRR they thought they would see associated with V was correct (which would have been based on looking at prior similar studies), then the study is clearly NOT underpowered. It is overpowered, which buys a little extra safety margin in case the RRR is a bit smaller than they anticipated.
I agree with those of you who feel the stock offering is a good thing, which insures the company can continue on its own to the end of RI without problems. It seems to me that the management stands to gain the most in their personal income by insuring that RI succeeds and that they do not have to partner (and share profits), which would raise the stock price and make the stock options which I assume are a big chunk of their compensation much more valuable.
For those of you who know how "the street" works, I am curious about something. I noticed that both Jeffries and HC Wainwright are involved in the new stock offering, and both in the past 6 months upgraded AMRN to a "Buy." Does this indicate they are pumping the stock in a quid pro quo for getting this work (which would seem counterproductive if they want to buy the stock cheaply before good news)? Or, does this indicate that these independent firms have evaluated the AMRN books and prospects closely, and really do strongly believe the price will go up substantially? Or, is it meaningless? I guess my question comes down to whether this is a situation where these firms' involvement in the stock offering and their recent upgrades can be taken as real evidence that those in the know feel confident about the future prospects for AMRN. Any opinions on this would be appreciated.
News 
Market Data 
Discover 
AI
